Genetic variants linked to acute intermittent porphyria vary according to ethnicity, a systematic analysis among eight ethnic populations…
Articles by Alice Melao
Adult patients with erythropoietic protoporphyria (EPP) who live in the United States can now be treated with Scenesse…
Treatment with investigational RNA-based therapy givosiran can safely reduce the annual incidence of acute hepatic porphyria (AHP)Â attacks, according to…
Once-monthly injections of givosiran can safely reduce the rate of recurrent porphyria attacks by effectively reducing disease-triggering neurotoxic compounds,…
High energy intake and insulin levels, as well as increased sugar and candy consumption, are associated with lower disease activity…
Canadian patients who have recurrent attacks of acute intermittent porphyria (AIP) can now be treated with Recordati Rare…
Results from a Phase 1 study and an open-label extension (OLE) trial have demonstrated that givosiran can effectively reduce…
Interim data from the ENVISION Phase 3 trial (NCT03338816) revealed Alnylam Pharmaceuticals’ lead candidate, givosiran, can effectively reduce the levels…
Physicians in Canada have reported the case of report of a 4-year-old boy whose delayed — and severe —reaction to…
Medical researchers in India have reported an unusual case of coexisting acute intermittent porphyria (AIP) and a genetic skin disorder…